Seqirus receives FDA approval of Afluria Quadrivalent (influenza vaccine) for people six months of age and older in the U.S.

17 October 2018 - Seqirus today announced the U.S. FDA has approved Afluria Quadrivalent (influenza vaccine) for use in people ...

Read more →

Flu vaccine supply shortfall triggered by unprecedented demand

21 May 2018 - An unprecedented increase in the number of people wanting flu vaccinations has caused a shortage in ...

Read more →

Update of EU recommendations for 2018/2019 seasonal flu vaccine composition

30 April 2018 - Update to recommendations issued in March 2018. ...

Read more →

PHARMAC turns down DHB request for free flu vaccine for 'super spreader' kids

24 April 2018 - Health authorities are bracing for a potentially deadly flu season in New Zealand this winter after ...

Read more →

2018 influenza vaccines now available

18 April 2018 - More than 4.5 million Australians who are most at risk of getting sick during this year’s flu ...

Read more →

2018 seasonal influenza vaccines

27 March 2018 - This year, four quadrivalent and two trivalent influenza vaccines will be available. ...

Read more →

EU recommendations for 2018/2019 seasonal flu vaccine composition

26 March 2018 - EU advice based on WHO recommendations. ...

Read more →

Statement from FDA Commissioner on FDA’s ongoing efforts to help improve effectiveness of influenza vaccines

26 February 2018 - The current influenza season has been especially difficult, causing widespread illness that has affected all fifty ...

Read more →

Influenza vaccine for 2018 season

12 February 2018 - PHARMAC is pleased to announce a quadrivalent influenza vaccine will be supplied for the 2018 influenza ...

Read more →

Seqirus receives FDA approval for Afluria Quadrivalent (influenza vaccine) for people 18 years of age and older

29 August 2016 - Seqirus is shipping trivalent and quadrivalent formulations of Afluria in the 2016-2017 influenza season. ...

Read more →

Agreement for supply of influenza vaccine approved by PHARMAC

5 August 2016 - PHARMAC is pleased to announce the approval of an agreement with BGP Products Pty Ltd (trading as ...

Read more →

TGA approves Afluria Quad

28 July 2016 - The TGA has approved CSL's Afluria Quad (quadrivalent influenza vaccine). ...

Read more →

FDA approves CSL's Flucelvax quadrivalent influenza vaccine

24 May 2016 - CSL today announced that the US FDA has approved Seqirus’ Flucelvax Quadrivalent (Influenza Vaccine), the first four-strain, ...

Read more →

TGA advice on 2016 seasonal influenza vaccines

8 April 2016 - The Australian Influenza Vaccine Committee (AIVC) has reviewed and evaluated data relating to the strains of influenza ...

Read more →